Arthur Berman
Gastroenterology · Largo, FLNPI 1730273236
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $18,155 of the $21,460 with a category attached, or 84.6%. Redhill Biopharma Inc. accounts for 91.6% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2021 at $10,032 and has fallen 54.2% since, to $4,592 in 2022. Among gastroenterology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 93 payments — averaging $230.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Redhill Biopharma Inc.$20K
- AbbVie$567
- Alfasigma USA, Inc.$527
- Johnson & Johnson$114
- Boston Scientific$103
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$96
- plus $390 from 11 others
Across 9 payments — averaging $6514.78 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$59K
What the payments were for
- Speaking & faculty fees$18,15585%
- Travel & lodging$1,6658%
- Food & beverage$1,5437%
- Education$850%
- Gifts$120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Redhill Biopharma Inc. | 21 | $19,663 |
| AbbVie(2 entities) | 31 | $567 |
| Alfasigma USA, Inc. | 3 | $527 |
| Johnson & Johnson | 9 | $114 |
| Boston Scientific | 1 | $103 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Aimmune Therapeutics, Inc. | 1 | $85 |
| Gilead | 6 | $83 |
| Pfizer | 5 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 2 | $37 |
| Shire North American Group Inc | 1 | $14 |
| Intercept Pharmaceuticals, Inc. | 1 | $14 |
| Merck | 1 | $13 |
| QOL Medical, LLC | 1 | $12 |
| Braintree Laboratories, Inc. | 1 | $12 |
| UCB, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Talicia$19,629
- Zelnorm$500
- Mavyret$115
- GENERAL POLYPECTOMY$103
How this compares
$21,460 in reported general payments places this provider in the 90th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Largo
- Meir MizrahiLargo$169K
- Michael SchulmanLargo$58K
- Samuel GidayOrlando$2M
- Lukasz KwapiszMiami$1.2M
- Jennifer Seminerio-DiehlOrlando$1.1M
- Udayakumar NavaneethanSaint Petersburg$1.1M
- Ronen AraiCoral Springs$1.1M
- Charles SninskyGainesville$983K
- Peter DraganovGainesville$832K
- Arin NewmanMiami Beach$716K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.